» Articles » PMID: 19220492

Risk Factors for Incident Diabetes Mellitus Among HIV-infected Patients Receiving Combination Antiretroviral Therapy in Taiwan: a Case-control Study

Overview
Journal HIV Med
Publisher Wiley
Date 2009 Feb 18
PMID 19220492
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Recent studies suggest that patients with HIV infection are at increased risk for incident diabetes mellitus (DM). We investigated the incidence and risk factors of DM among HIV-infected patients receiving combination antiretroviral therapy (CART) in Taiwan.

Methods: Incident cases of DM were identified among HIV-infected patients at the National Taiwan University Hospital between 1993 and 2006. A retrospective case-control study was conducted after matching cases with controls for sex, age at HIV diagnosis, year of HIV diagnosis, mode of HIV transmission and baseline CD4 lymphocyte count. A multivariate analysis was performed to identify risk factors for incident DM among HIV-infected patients.

Results: In 824 HIV-infected patients eligible for analysis, 50 cases of incident DM were diagnosed, resulting in an incidence of 13.1 cases per 1000 person-years of follow-up. In total, 100 matched controls were identified. Risk factors for incident DM were a family history of DM [odds ratio (OR) 2.656; 95% confidence interval (CI) 1.209-5.834], exposure to zidovudine (OR 3.168; 95% CI 1.159-8.661) and current use of protease inhibitors (OR 2.528; 95% CI 1.186-5.389).

Conclusions: Incident DM was associated with a family history of DM, exposure to zidovudine and current use of protease inhibitors in HIV-infected patients receiving CART in Taiwan.

Citing Articles

Expression of Killer Immunoglobulin Receptor Genes among HIV-Infected Individuals with Non-AIDS Comorbidities.

Abou Hassan F, Bou Hamdan M, El Asmar K, Melhem N J Immunol Res. 2022; 2022:1119611.

PMID: 35071606 PMC: 8769865. DOI: 10.1155/2022/1119611.


Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings.

Paengsai N, Jourdain G, Salvadori N, Tantraworasin A, Mary J, Cressey T Open Forum Infect Dis. 2019; 6(10):ofz298.

PMID: 31660327 PMC: 6778321. DOI: 10.1093/ofid/ofz298.


Diabetes, mortality and glucose monitoring rates in the TREAT Asia HIV Observational Database Low Intensity Transfer (TAHOD-LITE) study.

Bijker R, Kumarasamy N, Kiertiburanakul S, Pujari S, Sun L, Ng O HIV Med. 2019; 20(9):615-623.

PMID: 31338975 PMC: 7153907. DOI: 10.1111/hiv.12779.


Diabetes mellitus and its associated factors among human immunodeficiency virus-infected patients on anti-retroviral therapy in Northeast Ethiopia.

Fiseha T, Belete A BMC Res Notes. 2019; 12(1):372.

PMID: 31262341 PMC: 6604311. DOI: 10.1186/s13104-019-4402-1.


Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Colomb F, Giron L, Trbojevic-Akmacic I, Lauc G, Abdel-Mohsen M Curr HIV/AIDS Rep. 2019; 16(2):151-168.

PMID: 30707400 PMC: 6441623. DOI: 10.1007/s11904-019-00433-w.